Crossmark

The rising global tide of cognitive impairment

Crossref DOI link: https://doi.org/10.1038/nrneurol.2015.250

Published Online: 2016-01-18

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hampel, Harald

Lista, Simone
License Information

Text and Data Mining valid from 2016-01-18
More Information

Article History

First Online: 18 January 2016

Competing interests

: H.H. has received lecture honoraria from Biogen and Roche, research grants from Avid and Pfizer, travel funding from Axovant, Eli Lilly and company, GE Healthcare, Takeda and Zinfandel, consultancy fees from Anavex, Axovant, Cytox, GE Healthcare, Jung diagnostics, Takeda and Zinfandel, and participated in scientific advisory boards of Axovant, Cytox, GE Healthcare, Takeda and Zinfandel. He is co-inventor in (partly pending) patent submissions for which he has received no royalties. S.L. has received lecture honoraria from Roche.